Moderna plans to start testing flu vaccine

Sam Berger
Sam Berger

Author email
Posted Jan 12, 2021
Posted Jan 12, 2021
0

Pfizer and Moderna are testing their vaccines against UK coronavirus variant — In this July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. The U.S. is poised to give the green light as early as Friday, Dec. 18, to a second COVID-19 vaccine, a critical new weapon against the surging coronavirus. Doses of the vaccine developed by Moderna Inc. and the National Institutes of Health will give a much-needed boost to supplies as the biggest vaccination effort in the nation's history continues.
Hans Pennink/AP

KANSAS CITY, MO (KCTV) -- The maker of a popular coronavirus vaccine says similar technology could be used to tackle other dangerous viruses.

Moderna announced it will use its messenger RNA technology for experimental treatments of the seasonal flu, H.I.V. and the Nipah virus.

The pharmaceutical company believes its MRNA technology could help treat viruses that have, quote, "eluded traditional vaccine efforts."

Human trials on Moderna's flu vaccines are expected to begin later this year. The company also plans to begin clinical trials for two experimental vaccines against H.I.V. later this year.

KCTV5.com is now with you on the go! Get the latest news updates and video, StormTrack5 weather forecast, weather radar, special investigative reports, sports headlines and much more from KCTV5 News.

>> Click/tap here to download our free mobile app. <<